Technology | December 08, 2011

Varian Adds High-Dose Delivery and Prone Breast Treatment Capabilities

December 8, 2011 – Clinac and Trilogy medical linear accelerators from Varian Medical Systems, machines that are used to treat cancer with targeted radiotherapy, have been updated to deliver higher doses up to two times faster than was previously possible.  They can now also better facilitate treating breast cancer patients on their stomachs (in the prone position) rather than their backs—an approach that can reduce the volume of lung and heart tissue exposed to radiation during treatment.

Treatments Up to 50 Percent Faster

Updated control software, which received 510(k) clearance in November from the U.S. Food and Drug Administration (FDA), adds a High Intensity Mode to the Clinac and Trilogy machines, enabling dose delivery rates of up to 2400 monitor units per minute—double their former highest output. 

"Our High Intensity Mode makes it possible to deliver some treatments up to 50 percent faster than is possible without it," said Chris Toth, senior director of marketing for Varian's Oncology Systems business.  "We're seeing trends toward the use of hypo-fractionation and radiosurgical approaches for many types of cancer, which means that higher doses are delivered in just one or a few treatment sessions for quick ablation of a tumor.  There has been encouraging research supporting this approach for the treatment of cancers of the brain[1], spine[2], and lung[3], as well as for prostate cancer.[4]  With High Intensity Mode, our Clinac and Trilogy machines can deliver these high dose treatments within a clinically-feasible timeframe."

Supporting Breast Cancer Radiotherapy in the Prone Position

Varian also received FDA clearance for the Pivotal Care Solution for prone breast treatment, an innovation that allows patients to be treated on their stomachs rather than their backs.  Recent studies have shown that, for many women without axillary lymph node disease, treatment in the prone position can be used to significantly reduce the volume of lung and heart tissue exposed to the treatment beam.[5],[6]   

"When a woman is in the prone position for treatment, the targeted breast falls away from the rest of her body, creating a greater separation between the breast and the critical organs that lie behind her chest wall," Toth says.  "The Pivotal Solution makes it possible to treat an anatomical area that lies below the couch top, such as a breast that is hanging away from the rest of the body, enabling physicians to choose this approach if it is best for a particular patient.  Varian is committed to providing clinicians with tools that make it faster and easier to offer cancer patients advanced treatments that have the best likelihood of a positive outcome. 

For more information: www.varian.com

 

Related Content

Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
Fat Distribution in Women and Men Provides Clues to Heart Attack Risk
News | Women's Health | January 11, 2018
January 11, 2018 – It’s not the amount of fat in your body but where it is stored that may increase your risk for hea
Women Prefer Getting Mammograms Every Year
News | Mammography | January 09, 2018
Women prefer to get their mammograms every year, instead of every two years, according to a new study presented at the...
Planmed Clarity 2-D Digital Mammography System Receives FDA Approval
Technology | Mammography | January 08, 2018
The U.S. Food and Drug Administration (FDA) issued an approval letter for the Planmed Clarity 2-D full-field digital...
Overweight Women May Need More Frequent Mammograms
News | Mammography | January 04, 2018
Women with higher body mass index (BMI) face an increased risk of not detecting their breast tumor until it has become...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
About 25 percent of screening patients and 60 percent of diagnostic patients do not have prior mammograms available for comparison at the time of their examinations due to the lack of interoperability or other restrictions preventing clinicians from accessing prior exams.

About 25 percent of screening patients and 60 percent of diagnostic patients do not have prior mammograms available for comparison at the time of their examinations due to the lack of interoperability or other restrictions preventing clinicians from accessing prior exams.

Feature | Breast Imaging | January 02, 2018 | Kathryn Pearson Peyton, M.D.
Sixty million women undergo regular screening mammography in the United States, but even in the digital age, it is di
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
Imagio Opto-Acoustic Breast Imaging System Helps Differentiate Tumor Subtypes
News | Oncology Diagnostics | January 02, 2018
Seno Medical Instruments Inc. (Seno Medical) recently reported data from their clinical study demonstrating that its...
Overlay Init